Orbit Discovery

Orbit CEO, Neil Butt, will be speaking at the upcoming 5th Annual GPCR-Targeted Drug Discovery Summit in Boston later this month.

He will be giving a talk which describes how Orbit's functional peptide screening platform was used to find novel activators of the Mu and Delta Opioid Receptors.

Get in touch to learn more about how Orbit's platforms extend peptide discovery beyond finding simple binders and into identifying powerful functional modulators

‍

Work With Us

As administrators Sue Staunton and Sandra Mundy manage the business, affairs and property of the Company and its agents and without personal liability.

Orbit Discovery Limited registered in England and Wales no.12850396 Registered office The White Building 1-4 Cumberland PlaceSouthampton SO15 2NP. VAT registration number 359593151’.

‍
Orbit Discovery work with Big Pharma and
Small Biotechs alike.

Find out how Orbit Discovery can help with your peptide discovery needs

Orbit Discovery to Attend 5th Annual GPCRs Targeted Drug Discovery Summit